StockData
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc. (FULC) stock

FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.72−0.03 (-0.80%)

Close on Nov 18, 2026Market cap $283.83MP/E –Yield –

Fulcrum Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Fulcrum Therapeutics's price to sales ratio was 2.6× on Apr 30, 2025, against 157.4× a year earlier. Over the last 4 years it ranged from 1.9× to 229.8×, with a median of 32.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20252.6×−0.5
2024Dec 31, 20243.1×−131.1
2023Dec 29, 2023134.3×+112.0
2022Dec 30, 202222.3×−16.8
2021Dec 31, 202139.1×–

More Fulcrum Therapeutics figures

See a number that looks wrong?